600,000 Americans die each year as a result of heart disease, despite improvements in the diagnosis and treatment of cardiac problems. Recent dramatic success with heart transplantation has shown that replacement of the human heart can be achieved with remarkable prolongation of high-quality of life. Un fortunately, the limited availability of donor organs severely restricts the use of cardiac transplantation to a small minority of patients with end-stage heart failure. Recent developments in pump design and materials, however, suggest that the previously elusive goal of successful cardiac replacement with man-made pumps may soon be achieved. Experience with advanced-design wearable left ventricular assist devices used as """"""""bridges"""""""" to transplantation has been recently extended to periods of 100 to more than 500 days. Patients can enjoy a high quality of life outside of hospital, with low fail-safe mechanisms in device design allowing expeditious and effective treatment in rare instances of mechanical device failure. In light of the ongoing high incidence and poor prognosis of end-stage heart disease and encouraging process in mechanical circulatory assistance, we propose a three-center randomized clinical trial of the wearable Thermo cardiosystems left ventricular assist device versus medical therapy of heart failure in patients who are not candidates for cardiac transplantation. Our primary hypothesis is that such devices can reduce two-year mortality by 33% (from 75% to 50%). Randomization of total of 130 patients allows an 80% power to demonstrate the anticipated survival benefit. Rigorous assessment of quality of life and the cost-effectiveness of medical versus device therapy will also be conducted.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL053986-03
Application #
2901203
Study Section
Special Emphasis Panel (ZRG7-SB (02))
Project Start
1997-04-11
Project End
2001-03-31
Budget Start
1999-09-21
Budget End
2000-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Surgery
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Russo, Mark J; Gelijns, Annetine C; Stevenson, Lynne W et al. (2008) The cost of medical management in advanced heart failure during the final two years of life. J Card Fail 14:651-8
Park, Soon J; Tector, Alfred; Piccioni, William et al. (2005) Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129:9-17
Lazar, Ronald M; Shapiro, Peter A; Jaski, Brian E et al. (2004) Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 109:2423-7
Dembitsky, Walter P; Tector, Alfred J; Park, Soon et al. (2004) Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg 78:2123-9; discussion 2129-30
Huebert, Robert C; Li, Qinglu; Adhikari, Neeta et al. (2004) Identification and regulation of Sprouty1, a negative inhibitor of the ERK cascade, in the human heart. Physiol Genomics 18:284-9
Zhang, Wenwu; Yancey, Patricia G; Su, Yan Ru et al. (2003) Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108:2258-63
Oz, Mehmet C; Gelijns, Annetine C; Miller, Leslie et al. (2003) Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg 238:577-83; discussion 583-5
Moskowitz, A J; Rose, E A; Gelijns, A C (2001) The cost of long-term LVAD implantation. Ann Thorac Surg 71:S195-8; discussion S203-4
Rose, E A; Gelijns, A C; Moskowitz, A J et al. (2001) Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345:1435-43
Rose, E A; Moskowitz, A J; Packer, M et al. (1999) The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 67:723-30